146 related articles for article (PubMed ID: 35690338)
1. Cinobufagin inhibits tumor progression and reduces doxorubicin resistance by enhancing FOXO1-mediated transcription of FCGBP in osteosarcoma.
Ma X; Suo Z; Ma X; Zhan C; Luo G; Song J
J Ethnopharmacol; 2022 Oct; 296():115433. PubMed ID: 35690338
[TBL] [Abstract][Full Text] [Related]
2. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.
Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L
J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466
[TBL] [Abstract][Full Text] [Related]
3. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
Zhang C; Ma K; Li WY
Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
[TBL] [Abstract][Full Text] [Related]
4. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
Dai G; Zheng D; Guo W; Yang J; Cheng AY
Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353
[TBL] [Abstract][Full Text] [Related]
5. Silencing FUT4 Inhibits the Progression of Osteosarcoma through Activation of FOXO1.
Yang Y; Yan X; Chen Y; Liu J; Xue J; Sheng X; Qin J; Xue Q; Liu X
Curr Pharm Des; 2024; 30(6):440-447. PubMed ID: 38343056
[TBL] [Abstract][Full Text] [Related]
6. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Ma K; Zhang C; Huang MY; Li WY; Hu GQ
Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
[TBL] [Abstract][Full Text] [Related]
7. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract][Full Text] [Related]
8. Propofol suppresses osteosarcoma cell function by regulating FOXO1/TUSC7.
Huang X; Liu J; Xie H
J Pharm Pharmacol; 2021 Apr; 73(6):720-725. PubMed ID: 33724400
[TBL] [Abstract][Full Text] [Related]
9. Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling.
Cao Y; Yu L; Dai G; Zhang S; Zhang Z; Gao T; Guo W
Eur J Pharmacol; 2017 Jan; 794():77-84. PubMed ID: 27845066
[TBL] [Abstract][Full Text] [Related]
10. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
11. LAIR-1 overexpression inhibits epithelial-mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism.
Zhang J; Zhang Y; Cheng S; Mu Y; Liu Y; Yi X; Jiang D; Ding Y; Zhuang R
World J Surg Oncol; 2020 Jun; 18(1):136. PubMed ID: 32563267
[TBL] [Abstract][Full Text] [Related]
12. The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells.
Yin JQ; Wen L; Wu LC; Gao ZH; Huang G; Wang J; Zou CY; Tan PX; Yong BC; Jia Q; Shen JN
Toxicol Lett; 2013 Apr; 218(2):129-36. PubMed ID: 23164673
[TBL] [Abstract][Full Text] [Related]
13. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
14. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Represses the Aggressive Potential of Osteosarcoma.
Tahbazlahafi B; Paknejad M; Khaghani S; Sadegh-Nejadi S; Khalili E
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1312-1318. PubMed ID: 32955002
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of HCG18 Inhibits Cell Viability, Migration and Invasion in Pediatric Osteosarcoma by Targeting miR-188-5p/FOXC1 Axis.
Zhao Z; Chen J; Xia D
Mol Biotechnol; 2021 Sep; 63(9):807-817. PubMed ID: 34041718
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR-524/RASSF6 axis.
Zhou W; Liu Y; Wu X
J Gene Med; 2021 Oct; 23(10):e3373. PubMed ID: 34151476
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.
Qi F; Li A; Inagaki Y; Kokudo N; Tamura S; Nakata M; Tang W
Int Immunopharmacol; 2011 Mar; 11(3):342-9. PubMed ID: 21185919
[TBL] [Abstract][Full Text] [Related]
19. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma.
Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z
Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982
[TBL] [Abstract][Full Text] [Related]
20. Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway.
Ma K; Zhang C; Li W
Chem Biol Interact; 2020 Nov; 331():109275. PubMed ID: 33010222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
